Stellus Rx Acquires Tria Health

April 16, 2026

Stellus Rx, a technology-enabled pharmacy care management platform backed by WindRose Health Investors, acquired Tria Health, a pharmacist-led chronic condition support provider for self-insured employers. The combined offering is intended to create a single pharmacist-led platform to improve clinical outcomes and reduce total cost of care. Financial terms were not disclosed, and both brands are expected to operate independently in the near term during integration.

Buyers
Stellus Rx
Targets
Tria Health
Location
Missouri, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.